Maryland cardiologist Dr. Mark Midei had his license revoked by the state Board of Physicians over allegations that he implanted unnecessary coronary stents in 369 patients while working at St. Joseph Medical Center in Towson, Md. Midei will “more likely than not” appeal the decision, his lawyers told the Baltimore Business Journal. The story starts […]
After two Maryland cardiologists were implicated in healthcare fraud cases last year for allegedly implanting hundreds of unnecessary stents, the Society for Cardiovascular Angiography and Interventions and the Maryland chapter of the American College of Cardiology want the state's General Assembly to take action.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
There’s a lot of buzz this week about an unflattering report from the Senate Finance Committee (Staff Reports on Cardiac Stent Usage at St. Joseph’s Medical Center). This is a fairly extreme example. Most doctors don’t act this way, and medical device companies are not usually looking to work with doctors who get in trouble working with their devices.
A Baltimore-area doctor who was dismissed by his hospital for alleged fraud and sued by hundreds of patients in whom he implanted coronary stents manufactured by Abbott Laboratories (NYSE:ABT) was the recipient of research funding and gifts from the company, according to a newly released federal report. Abbott provided the perks to the St. Joseph […]
Jeff Kindler, a lawyer tapped as a fresh face to lead drugmaker Pfizer out of its dodrums, is out, after just a little over four years as chairman and chief excutive, reports NPR's health blog. Kindler's executive bio already has been erased from Pfizer's website. Ian C. Read, 57, head of the company's global biopharmaceuticals operations, is in.